Welcome to our dedicated page for Weyco Group SEC filings (Ticker: WEYS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Weyco Group, Inc. (NASDAQ: WEYS) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. Weyco Group is a Wisconsin-incorporated footwear company that designs and markets branded footwear for men, women, and children through North American wholesale and retail segments and other operations under Florsheim Australia.
Through this page, users can review Forms 10-K and 10-Q, which contain detailed discussions of segment performance for North American wholesale, North American retail, and other operations, as well as information on brands such as Florsheim, Nunn Bush, Stacy Adams, BOGS, Rafters, and Forsake. These periodic reports also incorporate risk factor discussions that the company references in its earnings releases, including commentary on tariffs, inflation, consumer demand, and sourcing from independent manufacturers.
Investors can also follow Form 8-K filings, where Weyco Group reports material events. Recent 8-Ks have disclosed special cash dividend declarations, quarterly earnings press releases furnished under Item 2.02, amendments to the company’s revolving credit facility with Associated Bank, and changes in board and finance leadership under Item 5.02. These filings provide insight into capital allocation decisions, liquidity arrangements, and corporate governance.
Stock Titan enhances these filings with AI-powered summaries that explain key points in clear language, helping users interpret complex sections on topics such as credit agreements, dividend actions, and segment results. Real-time updates from EDGAR ensure that new Weyco Group filings, including any proxy statements, current reports, or other required forms, appear promptly. Users interested in WEYS can rely on this page to navigate the company’s official regulatory record and better understand how management describes its operations, risks, and financial condition.
Weyco Group insider amendment: This amended Form 4 reports that Dustin Combs, who serves as a company officer and director (listed as VP, President - Bogs & Rafters), sold 585 shares of Weyco Group Inc. (WEYS) on 09/11/2025 at a price of $29.92 per share. The filing corrects an earlier error in the originally reported post-transaction beneficial ownership: the correct total is 3,455 shares following the sale, not 3,810 shares as first reported. The amendment was signed on 09/12/2025 and exists solely to fix the reported ownership amount.
Weyco Group Inc. (WEYS) Form 144 notice: The filer proposes to sell 585 shares of common stock through Goldman Sachs & Co. LLC on the NASD, with an approximate aggregate market value of $17,988.75. The securities were acquired in two option-exercise transactions from Weyco Group Inc.: 295 shares on 08/25/2025 and 290 shares on 08/26/2025, with payment characterized as option exercise. The filer reports no securities sold in the past three months. The filing includes the required representation that the seller is not aware of undisclosed material adverse information about the issuer.
Weyco Group insider amendment: This amended Form 4 corrects an earlier report of shares acquired by Thomas W. Florsheim Jr., Chairman & CEO and director. The transaction on 08/25/2025 was an acquisition of 3,095 shares (previously reported as 3,100 in error) at a reported price of $0. After the corrected transaction, Mr. Florsheim is shown as beneficially owning 809,511 shares. The amendment states it was filed solely to correct the amount acquired.
Brian Flannery filed a Form 4 reporting an acquisition of 1,695 shares of Weyco Group Inc. (WEYS) on 08/25/2025 at a reported price of $0, bringing his total beneficial ownership to 36,071 shares. The filing lists Mr. Flannery as a reporting person and indicates an officer/director relationship to the issuer.
The filing also discloses outstanding stock options exercisable into a total of 14,642 common shares across four option grants with exercise prices of $18.00, $24.00, $28.83 and $25.79, each vesting 20% per year over five years from their grant dates. The Form 4 is signed and dated 08/27/2025.
Tina M. Chang, a director of Weyco Group Inc. (WEYS), reported on Form 4 that she acquired 1,890 shares on 08/25/2025 under Transaction Code A, with $0 listed as the price, resulting in 18,036 shares beneficially owned after the transaction. The filing also discloses outstanding stock options exercisable into common stock from grants made 2018 through 2024, with exercise prices ranging from $18.00 to $37.22 and a total of 22,300 underlying shares shown across seven option grants. Each option grant vests 20% per year over five years as described in the explanation section.
Weyco Group Inc (WEYS) director Cory L. Nettles reported acquiring 1,890 shares of the company's common stock by a non‑derivative transaction on 08/25/2025 at a reported price of $0, increasing his beneficial ownership to 15,264 shares. The filing also lists multiple outstanding stock options granted in 2018–2024 with exercise prices ranging from $18.00 to $37.22 and standard five‑year vesting schedules (20% per year for five years). All listed holdings and derivative positions are reported as directly owned by the reporting person.
Fredrick P. Stratton Jr., a director of Weyco Group Inc. (WEYS), reported multiple transactions in the issuer's common stock on August 25-26, 2025. The Form 4 shows non-derivative activity including purchases and dispositions: an acquisition of 1,890 shares (code A) on 08/25/2025 and a series of transfers recorded under code Z totaling 1,810 shares across 08/25/2025 and 08/26/2025. Post-transactions, Mr. Stratton directly beneficially owned 4,940 shares and 3,880 shares on respective lines, and indirectly beneficially owned 104,927 and 104,617 shares held in trusts where he is trustee. Additional indirect holdings include 20,000 shares in the Ann Stratton Marital Trust B of 2005 and 30,300 shares in the Fred and Anne Stratton 2012 Family Trust.
The filing also lists outstanding stock options exercisable into common stock: 2,000 shares from an option with $37.22 exercise price (granted 08/23/2019, expires 08/23/2028) and four other option grants exercisable for 3,500 shares each with exercise prices of $18.00, $24.00, $28.83 and $25.79 and staggered grant dates of 08/26/2021, 08/25/2022, 08/25/2023 and 08/25/2024; all options follow 20% per year vesting schedules as noted.
Becky Jo Kryger, a director of Weyco Group Inc. (WEYS), reported an acquisition of company common stock. The Form 4 shows a transaction dated 08/25/2025 in which 945 shares were acquired under transaction code V (vested restricted stock) at a reported price of $0. Following the reported transaction the filing lists 945 shares beneficially owned by the reporting person. The form is signed by the reporting person on 08/27/2025.
Thomas W. Florsheim, Sr., a director of Weyco Group Inc. (WEYS), reported multiple transactions in the issuer's common stock on 08/25/2025 and 08/26/2025. The filing shows an acquisition of 1,890 shares on 08/25/2025 and additional reported adjustments on both dates that changed his direct beneficial ownership to 3,880 shares (direct). He also holds 554,173 shares indirectly in a revocable trust and 77,688 shares indirectly held by his wife. The form lists outstanding stock options exercisable into common stock (several tranches of 3,500 shares and one of 2,000 shares) with exercise prices ranging from $18.00 to $37.22 and expiration dates between 2027 and 2033.
Thomas W. Florsheim Jr., Chairman & CEO of Weyco Group Inc. (WEYS), reported on Form 4 the acquisition of 3,100 shares of WEYS common stock on 08/25/2025 at a reported price of $0. After the transaction he beneficially owns 809,511 shares directly and holds additional indirect interests: 52,113 (wife), 268,779 (as trustee for children), 221,873 (as trustee of John Florsheim Family Trust) and 94,619 (held in 2018 irrevocable trust). He also reports several outstanding stock options exercisable through 2033 aggregating 42,000 underlying shares. The Form 4 is signed 08/27/2025.